References
- Facts & Stats, Stats about international overdose[webpage on the Internet]. International Overdose Awareness Day; 2014. Available from:http://www.overdoseday.com/facts-stats/. Accessed March 27, 2015.
- Injury Prevention & Control: Prescription Drug Overdose [webpage on the Internet]. CDC. Centers for Disease Control and Prevention [cited April 3, 2015]. Available from http://www.cdc.gov/drugoverdose/index.html. Accessed January 2, 2015.
- Warner, M, Hedegaard, H, Chen, LH. Trends in Drug-Poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 1999–2012. Atlanta: National Center for Health Statistics; 2014. Available from: http://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning_deaths_1999-2012.pdf. Accessed January 20, 2015.
- Sadove MS, Balagot RC, Hatano S, Jobgen EA. Study of a narcotic antagonist – N-allyl-noroxymorphone. JAMA. 1963;183:666–668.
- Kuehn BM. Easy-to-use overdose antidote earns fast-track approval. JAMA. 2014;311(16):1600.
- Berteau C, Schwarzenbach F, Donazzolo Y, et al. Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers. Patient Prefer Adherence. 2010;4:379–388.
- Center for Drug Evaluation and Research. Summary Review: EVZIO. Silver Spring: US Food and Drug Administration; 2014. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205787Orig1s000SumR.pdf. Accessed January 28, 2015.
- Pharmacy Benefits Management Services. Naloxone Injection (EVZIO, Auto-injector): National PBM Abbreviated Drug Review. Washington (DC): US Department of Veterans Affairs; 2014. Available from: http://www.pbm.va.gov/PBM/clinicalguidance/abbreviatedreviews/Naloxone_Autoinjector_EVZIO_Abbreviated_Review_revised_2014_07_16.docx. Accessed January 28, 2015.
- Davis CS, Southwell JK, Niehaus VR, Walley AY, Dailey MW. Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med. 2014;21(10):1173–1177.
- Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3(7):660–667.
- Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103(10):1648–1657.
- Jones JD, Roux P, Stancliff S, Matthews W, Comer SD. Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users. Int J Drug Policy. 2014;25(1):166–170.
- Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009;104:2067–2074.
- Merlin MA, Saybolt M, Kapitanyan R, et al. Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. Am J Emerg Med. 2010;28:296–303.
- Sabzghabaee AM, Eizadi-Mood N, Yaraghi A, Zandifar S. Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial. Arch Med Sci. 2014;10:309–314.
- Strang J, Bird SM, Parmar MK. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: Rationale and practicalities for the N-ALIVE randomized trial. J Urban Health. 2013; 90(5):983–996.
- Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131–136.
- Behar E, Santos GM, Wheeler E, Rowe C, Coffin PO. Brief overdose education is sufficient for naloxone distribution to opioid users. Drug Alcohol Depend. 2015;148:209–212.
- Burris S, Norland J, Edlin B. Legal Aspect of Providing Naloxone to Heroin User in the United States. Temple Law School Working Papers. Int J of Drug Policy. 2001;12:237–248.
- Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death; a pilot intervention study. J Urban Health. 2005;82(2):303–311.
- Centers for Disease Control and Prevention (CDC). Community-based opioid overdose prevention programs providing naloxone – United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:101–105.
- Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
- Substance Abuse and Mental Health Services Administration (SAMHSA). Federal guidelines for opioid treatment programs; 2015. Available from: http://store.samhsa.gov/shin/content//PEP15-FEDGUIDEOTP/PEP15-FEDGUIDEOTP.pdf. Accessed January 8, 2015.
- Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA Opioid Overdose Toolkit: Five Essential Steps for First Responders. Available from: store.samhsa.gov/shin/content//SMA14-4742/Toolkit_FirstResponders.pdf. Accessed January 18, 2014.
- Rudolph SS, Jehu G, Nielsen SL, Nielsen K, Siersma V, Rasmussen LS. Prehospital treatment of opioid overdose in Copenhagen – Is it safe to discharge on-scene? Resuscitation. 2011;82(11):1414–1418.
- Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011;15(3):320–324.
- Vilke GM, Sloane C, Smith AM, Chan TC. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport. Acad Emerg Med. 2003;10(8):893–896.